Regencell Bioscience Holdings annual debt-to-assets ratio
2021
2022
2023
2024
2025
Regencell Bioscience Holdings Debt-to-Assets Ratio Growth & History (RGC)
Regencell Bioscience Holdings's debt-to-assets ratio was 0.09 for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 0.09 | 0.08 | +830.90% |
| 2024 | 2024-06-30 | 0.01 | −0.03 | −72.34% |
| 2023 | 2023-06-30 | 0.04 | −0.01 | −14.17% |
| 2022 | 2022-06-30 | 0.04 | −9.51 | −99.55% |
| 2021 | 2021-06-30 | 9.56 | — | — |
Regencell Bioscience Holdings quarterly debt-to-assets ratio
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-06-30 | 0.09 | 0.08 | +830.90% |
| Q4 2024 | 2024-06-30 | 0.01 | −0.03 | −72.34% |
| Q4 2023 | 2023-06-30 | 0.04 | −0.01 | −14.17% |
| Q4 2022 | 2022-06-30 | 0.04 | −9.51 | −99.55% |
| Q4 2021 | 2021-06-30 | 9.56 | — | — |
Regencell Bioscience Holdings debt-to-assets ratio trends
Between the periods ended 2021-06-30 and 2025-06-30, Regencell Bioscience Holdings's debt-to-assets ratio decreased from 9.56 to 0.09, a change of −9.46. The latest reported quarter, Q4 2025, shows 0.09.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗